The News International quoted Abdul Mannan, a Pharmacist as saying that the pricing policy of the Drug Regularity Authority of Pakistan (DRAP) is the reason why several life-saving drugs are not available in Pakistan.
“Due to the extreme depreciation of Pakistani currency against the dollar and the controversial drug pricing policy of the Drug Regularity Authority of Pakistan (DRAP), their prices have risen manifold and it has become economically unviable for importers to bring them on the existing prices given by the DRAP,” he said.
Heparin, a blood-thinning agent used following several cardiovascular procedures, is currently the most significant medicine that is not being given to healthcare facilities. Mannan urged the government to review the Drug Pricing Policy 2018 of DRAP right away, which permits a price increase under the hardship category.
Mannan claimed that DRAP permitted the import of medicines when the dollar was available at PKR 190, but that it now has increased to PKR 285 while the dollar is being traded at PKR 300 in the local market, The News International reported. Pakistan is going through one of its worst economic crises in years. Inflation has surged more than 30 per cent.
The Pakistani state usually offers relief packages during the month of Ramzan, but this year, the cash-strapped government have little to give. Rising inflation has made the lives of the people in the country extremely miserable as they are striving hard to buy the basic amenities, including medicines now as well.
